基因分型市场：按产品、技术和用途- 俄罗斯-乌克兰衝突、高通胀的累积影响 - 2023-2030 年全球预测

全球基因分型市场预计到2023年将大幅增长207.1亿美元，复合年增长率为14.12%，到2030年将达到惊人的522.9亿美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球基因分型市场至关重要。通过检查业务战略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的具体需求做出明智的资讯。这种高级分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市场份额分析

市场份额分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、积累和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发地区、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通胀的累积影响。

5、竞争评估与资讯：对主要企业的市场份额、战略、产品、认证、法规状况、专利状况、製造能力等进行综合评价。

6. 产品开发和创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1. 全球基因分型市场规模及预测是多少？

2. 在预测期内，COVID-19 对全球基因分型市场的抑制要素和影响是什么？

3. 在预测期内，全球基因分型市场需要投资哪些产品/细分市场/应用/领域？

4. 全球基因分型市场的竞争策略是什么？

5. 全球基因分型市场的技术趋势和法律规范是什么？

6. 全球基因分型市场主要厂商的市场份额是多少？

7. 哪些型态和战略倡议被认为适合进入全球基因分型市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

• 市场动态
  • 促进因素
    • 基因分型在药物研发发现和开发中日益重要
    • 帕金森病和特纳症候群等遗传疾病的患病率增加
    • 资料分析中生物信息学解决方案的潜在需求
  • 抑制因素
    • 相对昂贵的设备
  • 机会
    • 项目排序在世界范围内变得越来越重要
    • 农业产业持续需求
  • 任务
    • 缺乏训练有素的专家以及对基因分型资料管理的担忧
• 市场趋势
• COVID-19 的累积影响
• 俄罗斯-乌克兰衝突的累积影响
• 高通胀的累积效应
• 波特五力分析
• 价值炼和关键路径分析
• 法律规范
• 客户定制

第6章基因分型市场：副产品

• 设备和服务
• 试剂和试剂盒

第7章基因分型市场：按技术分类

• 毛细管电泳
• 质谱
• 微阵列
• PCR
• 顺序

第8章基因分型市场：按用途

• 诊断
• 药物研发

第9章美洲基因分型市场

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美国

第10章亚太基因分型市场

• 澳大利亚
• 中国
• 印度
• 印尼
• 日本
• 马来西亚
• 菲律宾
• 新加坡
• 韩国
• 台湾
• 泰国
• 越南

第11章欧洲/中东/非洲基因分型市场

• 丹麦
• 埃及
• 芬兰
• 法国
• 德国
• 以色列
• 义大利
• 荷兰
• 奈及利亚
• 挪威
• 波兰
• 卡达
• 俄罗斯
• 沙乌地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公国
• 英国

第12章竞争形势

• FPNV定位矩阵
• 市场份额分析：主要企业
• 竞争情景分析：主要企业

第13章上市公司名单

第14章附录

• 讨论指南
• 关于许可和定价

The Global Genotyping Market is forecasted to grow significantly, with a projected USD 20.71 billion in 2023 at a CAGR of 14.12% and expected to reach a staggering USD 52.29 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Genotyping Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Genotyping Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Instruments & Services and Reagents & Kits. The Instruments & Services is projected to witness significant market share during forecast period.

Based on Technology, market is studied across Capillary Electrophoresis, Mass Spectrometry, Microarray, PCR, and Sequencing. The Mass Spectrometry is projected to witness significant market share during forecast period.

Based on Application, market is studied across Diagnostics and Drug Discovery. The Drug Discovery is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Genotyping Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Genotyping Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Genotyping Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Genotyping Market?

4. What is the competitive strategic window for opportunities in the Global Genotyping Market?

5. What are the technology trends and regulatory frameworks in the Global Genotyping Market?

6. What is the market share of the leading vendors in the Global Genotyping Market?

7. What modes and strategic moves are considered suitable for entering the Global Genotyping Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Genotyping Market, by Product, 2022 vs 2030
• 4.3. Genotyping Market, by Technology, 2022 vs 2030
• 4.4. Genotyping Market, by Application, 2022 vs 2030
• 4.5. Genotyping Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing significance of genotyping in drug discovery and development
    • 5.1.1.2. Growing prevalence of genetic diseases such as Parkinson's, turner syndrome
    • 5.1.1.3. Potential demand for bioinformatics solutions in data analysis
  • 5.1.2. Restraints
    • 5.1.2.1. Relatively expensive equipment
  • 5.1.3. Opportunities
    • 5.1.3.1. Emerging importance of sequencing projects globally
    • 5.1.3.2. Ongoing demand in agriculture industries
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of trained professional and concerns in data management in genotyping
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Genotyping Market, by Product

• 6.1. Introduction
• 6.2. Instruments & Services
• 6.3. Reagents & Kits

7. Genotyping Market, by Technology

• 7.1. Introduction
• 7.2. Capillary Electrophoresis
• 7.3. Mass Spectrometry
• 7.4. Microarray
• 7.5. PCR
• 7.6. Sequencing

8. Genotyping Market, by Application

• 8.1. Introduction
• 8.2. Diagnostics
• 8.3. Drug Discovery

9. Americas Genotyping Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Genotyping Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Genotyping Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. FPNV Positioning Matrix
• 12.2. Market Share Analysis, By Key Player
• 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

• 14.1. Discussion Guide
• 14.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. GENOTYPING MARKET RESEARCH PROCESS
• FIGURE 2. GENOTYPING MARKET SIZE, 2022 VS 2030
• FIGURE 3. GENOTYPING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GENOTYPING MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
• FIGURE 5. GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
• FIGURE 6. GENOTYPING MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
• FIGURE 7. GENOTYPING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 8. GENOTYPING MARKET DYNAMICS
• FIGURE 9. GENOTYPING MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. GENOTYPING MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS GENOTYPING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES GENOTYPING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC GENOTYPING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. GENOTYPING MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 17. GENOTYPING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. GENOTYPING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. GENOTYPING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 5. GENOTYPING MARKET SIZE, BY INSTRUMENTS & SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. GENOTYPING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 8. GENOTYPING MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GENOTYPING MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GENOTYPING MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GENOTYPING MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GENOTYPING MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 14. GENOTYPING MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GENOTYPING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS GENOTYPING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 20. ARGENTINA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 23. BRAZIL GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. CANADA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. CANADA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 28. CANADA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. MEXICO GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 30. MEXICO GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. UNITED STATES GENOTYPING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 33. UNITED STATES GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. ASIA-PACIFIC GENOTYPING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 37. ASIA-PACIFIC GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. AUSTRALIA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. AUSTRALIA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. CHINA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. CHINA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 45. CHINA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. INDIA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. INDIA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 48. INDIA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. INDONESIA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. INDONESIA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. JAPAN GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. JAPAN GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. MALAYSIA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. MALAYSIA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. PHILIPPINES GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. PHILIPPINES GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. SINGAPORE GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. SINGAPORE GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. SOUTH KOREA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. SOUTH KOREA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. TAIWAN GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. TAIWAN GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. THAILAND GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. THAILAND GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. VIETNAM GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. VIETNAM GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 77. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. DENMARK GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. DENMARK GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. EGYPT GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. EGYPT GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. FINLAND GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. FINLAND GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. FRANCE GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. FRANCE GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. GERMANY GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. GERMANY GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. ISRAEL GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. ISRAEL GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. ITALY GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. ITALY GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 100. ITALY GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. NETHERLANDS GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. NETHERLANDS GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. NIGERIA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 105. NIGERIA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. NORWAY GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 108. NORWAY GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. POLAND GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111. POLAND GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 112. POLAND GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. QATAR GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. QATAR GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 115. QATAR GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. RUSSIA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 117. RUSSIA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. SAUDI ARABIA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 120. SAUDI ARABIA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. SOUTH AFRICA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH AFRICA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. SPAIN GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. SPAIN GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. SWEDEN GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 129. SWEDEN GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. SWITZERLAND GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. SWITZERLAND GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. TURKEY GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 135. TURKEY GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. UNITED ARAB EMIRATES GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. UNITED ARAB EMIRATES GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. UNITED KINGDOM GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 141. UNITED KINGDOM GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. GENOTYPING MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 144. GENOTYPING MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 145. GENOTYPING MARKET LICENSE & PRICING